vs
Side-by-side financial comparison of GUESS INC (GES) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $791.4M, roughly 1.4× GUESS INC). GUESS INC runs the higher net margin — 3.2% vs -127.8%, a 131.0% gap on every dollar of revenue. On growth, GUESS INC posted the faster year-over-year revenue change (7.2% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $-56.3M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -5.8%).
Guess?, Inc. is an American clothing company, notable for its black-and-white advertisements. It licenses its brand on other fashion accessories, such as watches, jewelry, perfumes, bags and shoes.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
GES vs PRGO — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $791.4M | $1.1B |
| Net Profit | $25.6M | $-1.4B |
| Gross Margin | 42.5% | 32.6% |
| Operating Margin | 2.9% | -116.0% |
| Net Margin | 3.2% | -127.8% |
| Revenue YoY | 7.2% | -2.5% |
| Net Profit YoY | 209.6% | -3093.9% |
| EPS (diluted) | $0.48 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $791.4M | $1.1B | ||
| Q3 25 | $772.9M | $1.0B | ||
| Q2 25 | $647.8M | $1.1B | ||
| Q1 25 | $932.3M | $1.0B | ||
| Q4 24 | $738.5M | $1.1B | ||
| Q3 24 | $732.6M | $1.1B | ||
| Q2 24 | $591.9M | $1.1B | ||
| Q1 24 | $891.0M | $1.1B |
| Q4 25 | $25.6M | $-1.4B | ||
| Q3 25 | $6.2M | $7.5M | ||
| Q2 25 | $-32.9M | $-8.4M | ||
| Q1 25 | $81.4M | $-6.4M | ||
| Q4 24 | $-23.4M | $-44.4M | ||
| Q3 24 | $-10.6M | $-21.0M | ||
| Q2 24 | $13.0M | $-108.4M | ||
| Q1 24 | $115.3M | $2.0M |
| Q4 25 | 42.5% | 32.6% | ||
| Q3 25 | 42.5% | 36.1% | ||
| Q2 25 | 39.9% | 34.4% | ||
| Q1 25 | 44.1% | 37.6% | ||
| Q4 24 | 43.6% | 33.9% | ||
| Q3 24 | 43.7% | 37.2% | ||
| Q2 24 | 41.9% | 37.0% | ||
| Q1 24 | 45.4% | 33.1% |
| Q4 25 | 2.9% | -116.0% | ||
| Q3 25 | 2.3% | 7.0% | ||
| Q2 25 | -5.1% | 4.3% | ||
| Q1 25 | 11.1% | 4.5% | ||
| Q4 24 | 5.7% | 10.0% | ||
| Q3 24 | 6.5% | 7.4% | ||
| Q2 24 | -3.4% | -2.5% | ||
| Q1 24 | 16.3% | -5.1% |
| Q4 25 | 3.2% | -127.8% | ||
| Q3 25 | 0.8% | 0.7% | ||
| Q2 25 | -5.1% | -0.8% | ||
| Q1 25 | 8.7% | -0.6% | ||
| Q4 24 | -3.2% | -3.9% | ||
| Q3 24 | -1.4% | -1.9% | ||
| Q2 24 | 2.2% | -10.2% | ||
| Q1 24 | 12.9% | 0.2% |
| Q4 25 | $0.48 | $-10.23 | ||
| Q3 25 | $0.12 | $0.05 | ||
| Q2 25 | $-0.65 | $-0.06 | ||
| Q1 25 | $1.29 | $-0.05 | ||
| Q4 24 | $-0.47 | $-0.32 | ||
| Q3 24 | $-0.28 | $-0.15 | ||
| Q2 24 | $0.23 | $-0.79 | ||
| Q1 24 | $1.90 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $154.2M | — |
| Total DebtLower is stronger | $299.5M | — |
| Stockholders' EquityBook value | $508.5M | $2.9B |
| Total Assets | $3.0B | $8.5B |
| Debt / EquityLower = less leverage | 0.59× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $154.2M | — | ||
| Q3 25 | $189.6M | $432.1M | ||
| Q2 25 | $151.2M | $454.2M | ||
| Q1 25 | $187.7M | $409.9M | ||
| Q4 24 | $140.9M | $558.8M | ||
| Q3 24 | $218.9M | $1.5B | ||
| Q2 24 | $241.7M | $542.8M | ||
| Q1 24 | $360.3M | $658.5M |
| Q4 25 | $299.5M | — | ||
| Q3 25 | $258.4M | — | ||
| Q2 25 | $241.7M | — | ||
| Q1 25 | $150.7M | — | ||
| Q4 24 | $238.3M | — | ||
| Q3 24 | $187.8M | — | ||
| Q2 24 | $196.9M | — | ||
| Q1 24 | $28.2M | — |
| Q4 25 | $508.5M | $2.9B | ||
| Q3 25 | $487.6M | $4.4B | ||
| Q2 25 | $483.6M | $4.5B | ||
| Q1 25 | $505.0M | $4.4B | ||
| Q4 24 | $450.7M | $4.3B | ||
| Q3 24 | $491.2M | $4.6B | ||
| Q2 24 | $565.5M | $4.5B | ||
| Q1 24 | $684.9M | $4.7B |
| Q4 25 | $3.0B | $8.5B | ||
| Q3 25 | $3.0B | $10.1B | ||
| Q2 25 | $2.9B | $10.1B | ||
| Q1 25 | $2.8B | $9.8B | ||
| Q4 24 | $2.8B | $9.6B | ||
| Q3 24 | $2.8B | $11.2B | ||
| Q2 24 | $2.7B | $10.4B | ||
| Q1 24 | $2.6B | $10.6B |
| Q4 25 | 0.59× | — | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-39.5M | $175.4M |
| Free Cash FlowOCF − Capex | $-56.3M | $148.6M |
| FCF MarginFCF / Revenue | -7.1% | 13.4% |
| Capex IntensityCapex / Revenue | 2.1% | 2.4% |
| Cash ConversionOCF / Net Profit | -1.54× | — |
| TTM Free Cash FlowTrailing 4 quarters | $62.5M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-39.5M | $175.4M | ||
| Q3 25 | $74.9M | $51.7M | ||
| Q2 25 | $-73.4M | $75.9M | ||
| Q1 25 | $183.2M | $-64.5M | ||
| Q4 24 | $-83.3M | $312.6M | ||
| Q3 24 | $44.7M | $42.2M | ||
| Q2 24 | $-22.9M | $9.5M | ||
| Q1 24 | $289.5M | $-1.4M |
| Q4 25 | $-56.3M | $148.6M | ||
| Q3 25 | $53.4M | $29.8M | ||
| Q2 25 | $-95.3M | $56.7M | ||
| Q1 25 | $160.7M | $-90.0M | ||
| Q4 24 | $-105.4M | $274.9M | ||
| Q3 24 | $24.3M | $15.1M | ||
| Q2 24 | $-44.0M | $-18.9M | ||
| Q1 24 | $267.8M | $-26.5M |
| Q4 25 | -7.1% | 13.4% | ||
| Q3 25 | 6.9% | 2.9% | ||
| Q2 25 | -14.7% | 5.4% | ||
| Q1 25 | 17.2% | -8.6% | ||
| Q4 24 | -14.3% | 24.2% | ||
| Q3 24 | 3.3% | 1.4% | ||
| Q2 24 | -7.4% | -1.8% | ||
| Q1 24 | 30.1% | -2.4% |
| Q4 25 | 2.1% | 2.4% | ||
| Q3 25 | 2.8% | 2.1% | ||
| Q2 25 | 3.4% | 1.8% | ||
| Q1 25 | 2.4% | 2.4% | ||
| Q4 24 | 3.0% | 3.3% | ||
| Q3 24 | 2.8% | 2.5% | ||
| Q2 24 | 3.6% | 2.7% | ||
| Q1 24 | 2.4% | 2.3% |
| Q4 25 | -1.54× | — | ||
| Q3 25 | 12.00× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.25× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.76× | — | ||
| Q1 24 | 2.51× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GES
| Products | $760.3M | 96% |
| Royalty | $31.1M | 4% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
